cdw corp. - CDW
CDW
Close Chg Chg %
140.77 1.85 1.31%
Closed Market
142.62
+1.85 (1.31%)
Volume: 1.69M
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: cdw corp. - CDW
CDW Key Data
| Open $140.55 | Day Range 139.77 - 142.72 |
| 52 Week Range 123.09 - 200.28 | Market Cap $17.98B |
| Shares Outstanding 130.19M | Public Float 129.64M |
| Beta 1.08 | Rev. Per Employee N/A |
| P/E Ratio 17.42 | EPS $8.13 |
| Yield 177.95% | Dividend $0.63 |
| EX-DIVIDEND DATE Feb 25, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.74M |
CDW Performance
| 1 Week | 12.84% | ||
| 1 Month | 6.84% | ||
| 3 Months | 0.12% | ||
| 1 Year | -25.73% | ||
| 5 Years | -5.53% |
CDW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
About cdw corp. - CDW
CDW Corp. engages in the provision of information technology solutions to small, medium, and large business, government, education, and healthcare customers. It operates through the following segments: Corporate, Small Business, Public, and Other. The Corporate segment serves US private sector business customers with more than 250 employees. The Small Business segment focuses on the US private sector business customers with up to 250 employees. The Public segment includes government agencies and education and healthcare institutions. The Other segment focuses on CDW UK and Canada. The company was founded by Michael P. Krasny in 1984 and is headquartered in Vernon Hills, IL.
CDW At a Glance
CDW Corp.
200 North Milwaukee Avenue
Vernon Hills, Illinois 60061
| Phone | 1-847-465-6000 | Revenue | 21.00B | |
| Industry | Information Technology Services | Net Income | 1.08B | |
| Sector | Technology Services | Employees | N/A | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
CDW Valuation
| P/E Current | 17.422 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 21.832 |
| Price to Sales Ratio | 1.121 |
| Price to Book Ratio | 9.809 |
| Price to Cash Flow Ratio | 18.42 |
| Enterprise Value to EBITDA | 15.059 |
| Enterprise Value to Sales | 1.39 |
| Total Debt to Enterprise Value | 0.219 |
CDW Efficiency
| Revenue/Employee | 1,390,642.384 |
| Income Per Employee | 71,377.483 |
| Receivables Turnover | 3.657 |
| Total Asset Turnover | 1.502 |
CDW Liquidity
| Current Ratio | 1.347 |
| Quick Ratio | 1.236 |
| Cash Ratio | 0.131 |
CDW Profitability
| Gross Margin | 21.918 |
| Operating Margin | 7.922 |
| Pretax Margin | 6.836 |
| Net Margin | 5.133 |
| Return on Assets | 7.709 |
| Return on Equity | 49.044 |
| Return on Total Capital | 12.343 |
| Return on Invested Capital | 14.046 |
CDW Capital Structure
| Total Debt to Total Equity | 271.148 |
| Total Debt to Total Capital | 73.057 |
| Total Debt to Total Assets | 43.46 |
| Long-Term Debt to Equity | 244.659 |
| Long-Term Debt to Total Capital | 65.92 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Cdw Corp. - CDW
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 20.82B | 23.75B | 21.38B | 21.00B | |
Sales Growth
| +12.74% | +14.06% | -9.99% | -1.77% | |
Cost of Goods Sold (COGS) incl D&A
| 17.25B | 19.06B | 16.72B | 16.40B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 191.00M | 291.00M | 271.00M | 275.00M | |
Depreciation
| 42.00M | 58.00M | 52.00M | 53.00M | |
Amortization of Intangibles
| 149.00M | 233.00M | 219.00M | 222.00M | |
COGS Growth
| +13.07% | +10.49% | -12.27% | -1.96% | |
Gross Income
| 3.57B | 4.69B | 4.65B | 4.60B | |
Gross Income Growth
| +11.16% | +31.33% | -0.73% | -1.07% | |
Gross Profit Margin
| +17.14% | +19.73% | +21.76% | +21.92% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 2.10B | 2.90B | 2.93B | 2.94B | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 2.10B | 2.90B | 2.93B | 2.94B | |
SGA Growth
| +3.60% | +38.56% | +0.87% | +0.36% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 60.30M | 49.90M | 43.00M | 12.20M | |
EBIT after Unusual Expense
| 1.41B | 1.73B | 1.68B | 1.65B | |
Non Operating Income/Expense
| 38.20M | (6.50M) | (4.10M) | (1.40M) | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 153.40M | 239.30M | 226.60M | 214.50M | |
Interest Expense Growth
| -4.66% | +56.00% | -5.31% | -5.34% | |
Gross Interest Expense
| 153.40M | 239.30M | 226.60M | 214.50M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 1.30B | 1.49B | 1.45B | 1.44B | |
Pretax Income Growth
| +29.48% | +14.64% | -2.53% | -1.02% | |
Pretax Margin
| +6.23% | +6.26% | +6.78% | +6.84% | |
Income Tax
| 309.20M | 373.30M | 345.90M | 357.60M | |
Income Tax - Current - Domestic
| 288.50M | 357.60M | 337.00M | 340.20M | |
Income Tax - Current - Foreign
| 27.40M | 33.90M | 41.60M | 31.50M | |
Income Tax - Deferred - Domestic
| (8.70M) | (15.00M) | (29.30M) | (14.00M) | |
Income Tax - Deferred - Foreign
| 2.00M | (3.20M) | (3.40M) | (100.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 988.60M | 1.11B | 1.10B | 1.08B | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 988.60M | 1.11B | 1.10B | 1.08B | |
Net Income Growth
| +25.38% | +12.74% | -0.92% | -2.40% | |
Net Margin Growth
| +4.75% | +4.69% | +5.17% | +5.13% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 988.60M | 1.11B | 1.10B | 1.08B | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 988.60M | 1.11B | 1.10B | 1.08B | |
EPS (Basic)
| 7.1379 | 8.2433 | 8.2043 | 8.0553 | |
EPS (Basic) Growth
| +29.09% | +15.49% | -0.47% | -1.82% | |
Basic Shares Outstanding
| 138.50M | 135.20M | 134.60M | 133.80M | |
EPS (Diluted)
| 7.0363 | 8.135 | 8.102 | 7.9719 | |
EPS (Diluted) Growth
| +29.22% | +15.61% | -0.41% | -1.61% | |
Diluted Shares Outstanding
| 140.50M | 137.00M | 136.30M | 135.20M | |
EBITDA
| 1.66B | 2.07B | 1.99B | 1.94B | |
EBITDA Growth
| +3.20% | +24.65% | -3.84% | -2.83% | |
EBITDA Margin
| +7.99% | +8.74% | +9.33% | +9.23% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 173.80 | |
| Number of Ratings | 14 | Current Quarters Estimate | 2.263 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 10.411 | |
| Last Quarter’s Earnings | 2.57 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 10.02 | Next Fiscal Year Estimate | 11.232 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 10 | 10 | 11 | 11 |
| Mean Estimate | 2.26 | 2.72 | 10.41 | 11.23 |
| High Estimates | 2.30 | 2.86 | 10.65 | 11.55 |
| Low Estimate | 2.22 | 2.55 | 9.39 | 10.47 |
| Coefficient of Variance | 1.02 | 3.38 | 3.46 | 2.88 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 7 | 8 |
| OVERWEIGHT | 2 | 2 | 2 |
| HOLD | 5 | 5 | 4 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Cdw Corp. - CDW
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Cdw Corp. - CDW
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 4, 2025 | David W. Nelms Director | 30,097 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 4, 2025 | Joseph R. Swedish Director | 17,497 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 21, 2025 | Katherine Elizabeth Sanderson See Remarks | 21,766 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $167 per share | 3,634,922.00 |
| Mar 14, 2025 | Marc E. Jones Director | 2,826 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Christine A. Leahy See Remarks; Director | 145,924 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Virginia C. Addicott Director | 16,607 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Elizabeth H. Connelly See Remarks | 22,498 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share | 3,735,792.90 |
| Mar 14, 2025 | Elizabeth H. Connelly See Remarks | 22,662 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Frederick J. Kulevich See Remarks | 36,077 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share | 5,990,585.85 |
| Mar 14, 2025 | Frederick J. Kulevich See Remarks | 36,302 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Anthony R. Foxx Director | 4,994 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Kelly Jean Grier Director | 2,418 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Christine A. Leahy See Remarks; Director | 144,931 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share | 24,065,792.55 |
| Mar 14, 2025 | Lynda M. Clarizio Director | 14,442 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Sona Chawla See Remarks | 35,439 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share | 5,884,645.95 |
| Mar 14, 2025 | Sona Chawla See Remarks | 35,937 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Sanjay Mehrotra Director | 4,739 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Donna F. Zarcone Director | 21,110 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 14, 2025 | Albert Joseph Miralles See Remarks | 32,999 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share | 5,479,483.95 |
| Mar 14, 2025 | Albert Joseph Miralles See Remarks | 33,364 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |